These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21658003)

  • 21. The binding properties of minimal oligosaccharides reveal a common heparan sulfate/dermatan sulfate-binding site in hepatocyte growth factor/scatter factor that can accommodate a wide variety of sulfation patterns.
    Deakin JA; Blaum BS; Gallagher JT; Uhrín D; Lyon M
    J Biol Chem; 2009 Mar; 284(10):6311-21. PubMed ID: 19114710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the interaction between Robo1 and heparin and other glycosaminoglycans.
    Zhang F; Moniz HA; Walcott B; Moremen KW; Linhardt RJ; Wang L
    Biochimie; 2013 Dec; 95(12):2345-53. PubMed ID: 23994753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain.
    Mamluk R; Gechtman Z; Kutcher ME; Gasiunas N; Gallagher J; Klagsbrun M
    J Biol Chem; 2002 Jul; 277(27):24818-25. PubMed ID: 11986311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heparinase I acts on a synthetic heparin pentasaccharide corresponding to the antithrombin III binding site.
    Yu G; LeBrun L; Gunay NS; Hoppensteadt D; Walenga JM; Fareed J; Linhardt RJ
    Thromb Res; 2000 Dec; 100(6):549-56. PubMed ID: 11152935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of the Heparin-Binding Consensus Sequence of β-Amyloid Peptides with Heparin and Heparin-Derived Oligosaccharides.
    Nguyen K; Rabenstein DL
    J Phys Chem B; 2016 Mar; 120(9):2187-97. PubMed ID: 26872053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disulfide structure of the heparin binding domain in vascular endothelial growth factor: characterization of posttranslational modifications in VEGF.
    Keck RG; Berleau L; Harris R; Keyt BA
    Arch Biochem Biophys; 1997 Aug; 344(1):103-13. PubMed ID: 9244387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VEGF and VEGFR2 bind to similar pH-sensitive sites on fibronectin, exposed by heparin-mediated conformational changes.
    Usuelli M; Meyer T; Mezzenga R; Mitsi M
    J Biol Chem; 2021; 296():100584. PubMed ID: 33771558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solution structure of the heparin-binding domain of vascular endothelial growth factor.
    Fairbrother WJ; Champe MA; Christinger HW; Keyt BA; Starovasnik MA
    Structure; 1998 May; 6(5):637-48. PubMed ID: 9634701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells.
    Cohen T; Gitay-Goren H; Sharon R; Shibuya M; Halaban R; Levi BZ; Neufeld G
    J Biol Chem; 1995 May; 270(19):11322-6. PubMed ID: 7744769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells.
    Gitay-Goren H; Cohen T; Tessler S; Soker S; Gengrinovitch S; Rockwell P; Klagsbrun M; Levi BZ; Neufeld G
    J Biol Chem; 1996 Mar; 271(10):5519-23. PubMed ID: 8621410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.
    Soker S; Fidder H; Neufeld G; Klagsbrun M
    J Biol Chem; 1996 Mar; 271(10):5761-7. PubMed ID: 8621443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the Interactions of Different Growth Factors and Glycosaminoglycans.
    Zhang F; Zheng L; Cheng S; Peng Y; Fu L; Zhang X; Linhardt RJ
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31527407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparin.
    Shriver Z; Sundaram M; Venkataraman G; Fareed J; Linhardt R; Biemann K; Sasisekharan R
    Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10365-70. PubMed ID: 10984532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor.
    Aviezer D; Levy E; Safran M; Svahn C; Buddecke E; Schmidt A; David G; Vlodavsky I; Yayon A
    J Biol Chem; 1994 Jan; 269(1):114-21. PubMed ID: 8276782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structures of five sulfated hexasaccharides prepared from porcine intestinal heparin using bacterial heparinase. Structural variants with apparent biosynthetic precursor-product relationships for the antithrombin III-binding site.
    Tsuda H; Yamada S; Yamane Y; Yoshida K; Hopwood JJ; Sugahara K
    J Biol Chem; 1996 May; 271(18):10495-502. PubMed ID: 8631846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides.
    Fromm JR; Hileman RE; Weiler JM; Linhardt RJ
    Arch Biochem Biophys; 1997 Oct; 346(2):252-62. PubMed ID: 9343372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation.
    Pala L; Cresci B; Manuelli C; Maggi E; Yamaguchi YF; Cappugi P; Rotella CM; Giannini S
    Microvasc Res; 2005 Nov; 70(3):179-88. PubMed ID: 16271941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A major common trisulfated hexasaccharide core sequence, hexuronic acid(2-sulfate)-glucosamine(N-sulfate)-iduronic acid-N-acetylglucosamine-glucuronic acid-glucosamine(N-sulfate), isolated from the low sulfated irregular region of porcine intestinal heparin.
    Yamada S; Yamane Y; Tsuda H; Yoshida K; Sugahara K
    J Biol Chem; 1998 Jan; 273(4):1863-71. PubMed ID: 9442018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of oligosaccharide ligands for hepatocyte growth factor/scatter factor (HGF/SF), keratinocyte growth factor (KGF/FGF-7), RANTES and heparin cofactor II by neoglycolipid microarrays of glycosaminoglycan-derived oligosaccharide fragments.
    Yamaguchi K; Tamaki H; Fukui S
    Glycoconj J; 2006 Nov; 23(7-8):513-23. PubMed ID: 17006643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple mechanisms for exogenous heparin modulation of vascular endothelial growth factor activity.
    Wijelath E; Namekata M; Murray J; Furuyashiki M; Zhang S; Coan D; Wakao M; Harris RB; Suda Y; Wang L; Sobel M
    J Cell Biochem; 2010 Oct; 111(2):461-8. PubMed ID: 20524207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.